These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 152335)

  • 41. Acne vaccines targeting Propionibacterium acnes.
    Kao M; Huang CM
    G Ital Dermatol Venereol; 2009 Dec; 144(6):639-43. PubMed ID: 19907403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis.
    Christensen GJ; Scholz CF; Enghild J; Rohde H; Kilian M; Thürmer A; Brzuszkiewicz E; Lomholt HB; Brüggemann H
    BMC Genomics; 2016 Feb; 17():152. PubMed ID: 26924200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine].
    Załuga E
    Ann Acad Med Stetin; 1998; 44():65-85. PubMed ID: 9857532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Propionibacterium acnes: an update on its role in the pathogenesis of acne.
    Beylot C; Auffret N; Poli F; Claudel JP; Leccia MT; Del Giudice P; Dreno B
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):271-8. PubMed ID: 23905540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Superoxide dismutase and myeloperoxidase activities in polymorphonuclear leukocytes in acne vulgaris.
    Kurutas EB; Arican O; Sasmaz S
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Jun; 14(2):39-42. PubMed ID: 16001098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of comedonal and skin surface lipids from hairless dogs showing clinical signs of acne.
    Bedord CJ; Young JM
    J Invest Dermatol; 1981 Oct; 77(4):341-4. PubMed ID: 6456312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A possible role for squalene in the pathogenesis of acne. II. In vivo study of squalene oxides in skin surface and intra-comedonal lipids of acne patients.
    Saint-Leger D; Bague A; Lefebvre E; Cohen E; Chivot M
    Br J Dermatol; 1986 May; 114(5):543-52. PubMed ID: 2941050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acne: a new model of immune-mediated chronic inflammatory skin disease.
    Antiga E; Verdelli A; Bonciani D; Bonciolini V; Caproni M; Fabbri P
    G Ital Dermatol Venereol; 2015 Apr; 150(2):247-54. PubMed ID: 25876146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cytotoxicity in acne vulgaris].
    Vignale RA; Espasandín J; Lasalvia E; Borras A
    Med Cutan Ibero Lat Am; 1982; 10(1):31-6. PubMed ID: 6214674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III.
    Schaller M; Loewenstein M; Borelli C; Jacob K; Vogeser M; Burgdorf WH; Plewig G
    Br J Dermatol; 2005 Jul; 153(1):66-71. PubMed ID: 16029328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sampling and detection of skin Propionibacterium acnes: current status.
    Alexeyev OA; Jahns AC
    Anaerobe; 2012 Oct; 18(5):479-83. PubMed ID: 22877737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delayed hypersensitivity to Propionibacterium acnes in patients with severe nodular acne and acne fulminans.
    Karvonen SL; Räsänen L; Cunliffe WJ; Holland KT; Karvonen J; Reunala T
    Dermatology; 1994; 189(4):344-9. PubMed ID: 7873817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Newer approaches in topical combination therapy for acne.
    Fu LW; Vender RB
    Skin Therapy Lett; 2011 Oct; 16(9):3-6. PubMed ID: 22089505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple Activities of Punica granatum Linne against Acne Vulgaris.
    Lee CJ; Chen LG; Liang WL; Wang CC
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What's new in acne and inflammation?
    Stein Gold LF
    J Drugs Dermatol; 2013 Jun; 12(6):s67-9. PubMed ID: 23839203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
    Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
    J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies.
    Dessinioti C; Katsambas AD
    Clin Dermatol; 2010; 28(1):2-7. PubMed ID: 20082942
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evolving concepts in the pathogenesis of acne vulgaris.
    Kircik LH
    J Drugs Dermatol; 2014 Jun; 13(6):s56. PubMed ID: 24918571
    [No Abstract]   [Full Text] [Related]  

  • 59. The effect of Propionibacterium acnes on maturation of dendritic cells derived from acne patients' peripherial blood mononuclear cells.
    Michalak-Stoma A; Tabarkiewicz J; Olender A; Juszkiewicz-Borowiec M; Stoma F; Pietrzak A; Pozarowski P; Bartkowiak-Emeryk M
    Folia Histochem Cytobiol; 2008; 46(4):535-9. PubMed ID: 19141410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [On the propionibacteria in the pilosebaceous ducts of uninvolved skin of acne patients. Investigations on juvenile acne patients with predominant comedones and healthy controls (author's transl)].
    Gloor M; Lamerz A; Höffler U; Franke M
    Dermatol Monatsschr; 1980 Dec; 166(12):798-803. PubMed ID: 6452296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.